These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 8473508

  • 1. Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function.
    Holleran WM, Takagi Y, Menon GK, Legler G, Feingold KR, Elias PM.
    J Clin Invest; 1993 Apr; 91(4):1656-64. PubMed ID: 8473508
    [Abstract] [Full Text] [Related]

  • 2. Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease.
    Holleran WM, Ginns EI, Menon GK, Grundmann JU, Fartasch M, McKinney CE, Elias PM, Sidransky E.
    J Clin Invest; 1994 Apr; 93(4):1756-64. PubMed ID: 8163674
    [Abstract] [Full Text] [Related]

  • 3. Permeability barrier requirements regulate epidermal beta-glucocerebrosidase.
    Holleran WM, Takagi Y, Menon GK, Jackson SM, Lee JM, Feingold KR, Elias PM.
    J Lipid Res; 1994 May; 35(5):905-12. PubMed ID: 8071612
    [Abstract] [Full Text] [Related]

  • 4. Human epidermal glucosylceramides are major precursors of stratum corneum ceramides.
    Hamanaka S, Hara M, Nishio H, Otsuka F, Suzuki A, Uchida Y.
    J Invest Dermatol; 2002 Aug; 119(2):416-23. PubMed ID: 12190865
    [Abstract] [Full Text] [Related]

  • 5. Glucosylceramides stimulate mitogenesis in aged murine epidermis.
    Marchell NL, Uchida Y, Brown BE, Elias PM, Holleran WM.
    J Invest Dermatol; 1998 Apr; 110(4):383-7. PubMed ID: 9540979
    [Abstract] [Full Text] [Related]

  • 6. Structural basis for the barrier abnormality following inhibition of HMG CoA reductase in murine epidermis.
    Menon GK, Feingold KR, Mao-Qiang M, Schaude M, Elias PM.
    J Invest Dermatol; 1992 Feb; 98(2):209-19. PubMed ID: 1732385
    [Abstract] [Full Text] [Related]

  • 7. Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities.
    Kao JS, Fluhr JW, Man MQ, Fowler AJ, Hachem JP, Crumrine D, Ahn SK, Brown BE, Elias PM, Feingold KR.
    J Invest Dermatol; 2003 Mar; 120(3):456-64. PubMed ID: 12603860
    [Abstract] [Full Text] [Related]

  • 8. The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model.
    Ghadially R, Brown BE, Sequeira-Martin SM, Feingold KR, Elias PM.
    J Clin Invest; 1995 May; 95(5):2281-90. PubMed ID: 7738193
    [Abstract] [Full Text] [Related]

  • 9. Sphingolipids are required for mammalian epidermal barrier function. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation.
    Holleran WM, Man MQ, Gao WN, Menon GK, Elias PM, Feingold KR.
    J Clin Invest; 1991 Oct; 88(4):1338-45. PubMed ID: 1918384
    [Abstract] [Full Text] [Related]

  • 10. The role of sphingolipid metabolism in cutaneous permeability barrier formation.
    Breiden B, Sandhoff K.
    Biochim Biophys Acta; 2014 Mar; 1841(3):441-52. PubMed ID: 23954553
    [Abstract] [Full Text] [Related]

  • 11. Secretory phospholipase A2 activity is required for permeability barrier homeostasis.
    Mao-Qiang M, Jain M, Feingold KR, Elias PM.
    J Invest Dermatol; 1996 Jan; 106(1):57-63. PubMed ID: 8592082
    [Abstract] [Full Text] [Related]

  • 12. Glucosylceramide metabolism is regulated during normal and hormonally stimulated epidermal barrier development in the rat.
    Hanley K, Jiang Y, Holleran WM, Elias PM, Williams ML, Feingold KR.
    J Lipid Res; 1997 Mar; 38(3):576-84. PubMed ID: 9101438
    [Abstract] [Full Text] [Related]

  • 13. Localization of ceramide and glucosylceramide in human epidermis by immunogold electron microscopy.
    Vielhaber G, Pfeiffer S, Brade L, Lindner B, Goldmann T, Vollmer E, Hintze U, Wittern KP, Wepf R.
    J Invest Dermatol; 2001 Nov; 117(5):1126-36. PubMed ID: 11710923
    [Abstract] [Full Text] [Related]

  • 14. Dietary glucosylceramide improves skin barrier function in hairless mice.
    Tsuji K, Mitsutake S, Ishikawa J, Takagi Y, Akiyama M, Shimizu H, Tomiyama T, Igarashi Y.
    J Dermatol Sci; 2006 Nov; 44(2):101-7. PubMed ID: 17000082
    [Abstract] [Full Text] [Related]

  • 15. beta-Glucocerebrosidase activity in murine epidermis: characterization and localization in relation to differentiation.
    Holleran WM, Takagi Y, Imokawa G, Jackson S, Lee JM, Elias PM.
    J Lipid Res; 1992 Aug; 33(8):1201-9. PubMed ID: 1431599
    [Abstract] [Full Text] [Related]

  • 16. Exogenous lipids influence permeability barrier recovery in acetone-treated murine skin.
    Man MQ, Feingold KR, Elias PM.
    Arch Dermatol; 1993 Jun; 129(6):728-38. PubMed ID: 8507075
    [Abstract] [Full Text] [Related]

  • 17. Permeability barrier disorder in Niemann-Pick disease: sphingomyelin-ceramide processing required for normal barrier homeostasis.
    Schmuth M, Man MQ, Weber F, Gao W, Feingold KR, Fritsch P, Elias PM, Holleran WM.
    J Invest Dermatol; 2000 Sep; 115(3):459-66. PubMed ID: 10951284
    [Abstract] [Full Text] [Related]

  • 18. An accumulation of glucosylceramide in the stratum corneum due to attenuated activity of beta-glucocerebrosidase is associated with the early phase of UVB-induced alteration in cutaneous barrier function.
    Takagi Y, Nakagawa H, Yaginuma T, Takema Y, Imokawa G.
    Arch Dermatol Res; 2005 Jul; 297(1):18-25. PubMed ID: 15912415
    [Abstract] [Full Text] [Related]

  • 19. Omega-hydroxyceramides are required for corneocyte lipid envelope (CLE) formation and normal epidermal permeability barrier function.
    Behne M, Uchida Y, Seki T, de Montellano PO, Elias PM, Holleran WM.
    J Invest Dermatol; 2000 Jan; 114(1):185-92. PubMed ID: 10620136
    [Abstract] [Full Text] [Related]

  • 20. Avian permeability barrier function reflects mode of sequestration and organization of stratum corneum lipids: reevaluation utilizing ruthenium tetroxide staining and lipase cytochemistry.
    Menon GK, Hou SY, Elias PM.
    Tissue Cell; 1991 Jan; 23(4):445-56. PubMed ID: 1718053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.